Refinement of the Smith-Magenis syndrome critical region to approximately 950kb and assessment of 17p11.2 deletions. Are all deletions created equally?

Graduate Program in Genetics, Michigan State University, S-320 Plant Biology Building, 178 Wilson Road, East Lansing, MI 48824, USA.
Molecular Genetics and Metabolism (Impact Factor: 2.63). 07/2003; 79(2):134-41. DOI: 10.1016/S1096-7192(03)00048-9
Source: PubMed


Smith-Magenis syndrome (SMS) is a multiple congenital anomalies/mental retardation syndrome associated with an interstitial deletion of chromosome 17p11.2. SMS is thought to be a contiguous gene syndrome caused by haploinsufficiency of one or more genes in the associated deletion region. To date, no gene has been reported to contribute to the characteristics seen in the SMS phenotype. To expedite the search for the SMS causative genes, we have reduced the SMS critical region to approximately 950kb by analyzing 11 patient samples carrying 17p11.2 deletions. In addition, we have re-evaluated the frequency with which different 17p11.2 deletions naturally occur, showing evidence that homologous recombination likely takes place between low copy repeats at a higher frequency than previously reported.

7 Reads
  • Source
    • "encompassing the retinoic acid-induced 1 (RAI1) gene or a deleterious mutation of RAI1 [2], [3]. RAI1 is a dosage-sensitive gene that encodes a transcriptional regulator known to bind to the nucleosome core and histones [4], and haploinsufficiency of RAI1 results in the SMS phenotype [2], [3]. Interestingly, individuals with SMS can also have a wide range of phenotypic variability [5], [6], likely due to a variety of genetic factors such as natural genetic variation modifying the phenotype, complex epistatic interactions, and the modifying effects of the environment. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Smith-Magenis syndrome is a complex genomic disorder in which a majority of individuals are obese by adolescence. While an interstitial deletion of chromosome 17p11.2 is the leading cause, mutation or deletion of the RAI1 gene alone results in most features of the disorder. Previous studies have shown that heterozygous knockout of Rai1 results in an obese phenotype in mice and that Smith-Magenis syndrome mouse models have a significantly reduced fecundity and an altered transmission pattern of the mutant Rai1 allele, complicating large, extended studies in these models. In this study, we show that breeding C57Bl/6J Rai1+/- mice with FVB/NJ to create F1 Rai1+/- offspring in a mixed genetic background ameliorates both fecundity and Rai1 allele transmission phenotypes. These findings suggest that the mixed background provides a more robust platform for breeding and larger phenotypic studies. We also characterized the effect of dietary intake on Rai1+/- mouse growth during adolescent and early adulthood developmental stages. Animals fed a high carbohydrate or a high fat diet gained weight at a significantly faster rate than their wild type littermates. Both high fat and high carbohydrate fed Rai1+/- mice also had an increase in body fat and altered fat distribution patterns. Interestingly, Rai1+/- mice fed different diets did not display altered fasting blood glucose levels. These results suggest that dietary regimens are extremely important for individuals with Smith- Magenis syndrome and that food high in fat and carbohydrates may exacerbate obesity outcomes.
    PLoS ONE 08/2014; 9(8):e105077. DOI:10.1371/journal.pone.0105077 · 3.23 Impact Factor
  • Source
    • "The remaining WAGR samples diagnosed by genome-wide aCGH were described previously [6]. DNA samples of Smith-Magenis and Potocki-Lupski patients diagnosed by FISH or metaphase karyotyping were published previously [7]. In order to simulate Xp22.3 microdeletions, we used normal female and male samples as control individuals and affected samples, respectively. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Detection of human microdeletion and microduplication syndromes poses significant burden on public healthcare systems in developing countries. With genome-wide diagnostic assays frequently inaccessible, targeted low-cost PCR-based approaches are preferred. However, their reproducibility depends on equally efficient amplification using a number of target and control primers. To address this, the recently described technique called Microdeletion/Microduplication Quantitative Fluorescent PCR (MQF-PCR) was shown to reliably detect four human syndromes by quantifying DNA amplification in an internally controlled PCR reaction. Here, we confirm its utility in the detection of eight human microdeletion syndromes, including the more common WAGR, Smith-Magenis, and Potocki-Lupski syndromes with 100% sensitivity and 100% specificity. We present selection, design, and performance evaluation of detection primers using variety of approaches. We conclude that MQF-PCR is an easily adaptable method for detection of human pathological chromosomal aberrations.
    Disease markers 10/2013; 35(6):589-594. DOI:10.1155/2013/704917 · 1.56 Impact Factor
  • Source
    • "The commercial DNA probes for diagnosis by FISH are located on FLII and RAI1 genes; both are located in region 17p11.2. (Vlangos et al., 2003). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Smith-Magenis syndrome (SMS) is a complex congenital anomaly characterized by craniofacial anomalies, neurological and behavioral disorders. SMS is caused by a deletion in region 17p11.2, which includes the RAI1 gene (90% of cases), or by point mutation in the RAI1 gene (10% of cases). Laboratory diagnosis is through cytogenetic analysis by GTG banding and molecular cytogenetic analysis by FISH. We carried out an active search for patients in Associations of Parents and Friends of Exceptional Children (APAE) of São Paulo and genetic centers in Brazil. Forty-eight patients were screened for mental retardation, craniofacial abnormalities and stereotyped behavior with a diagnosis of SMS. In seven of them, chromosome banding at high resolution demonstrated chromosome 17p11.2 deletions, confirmed by FISH. We also made a meta-analysis of 165 cases reported between 1982 and 2010 to compare with the clinical data of our sample. We demonstrated differences between the frequencies of clinical signs among the cases reported and seven Brazilian cases of this study, such as dental anomalies, strabismus, ear infections, deep hoarse voice, hearing loss, and cardiac defects. Although the gold standard for diagnosis of SMS is FISH, we found that the GTG banding technique developed to evaluate chromosome 17 can be used for the SMS diagnosis in areas where the FISH technique is not available.
    Genetics and molecular research: GMR 01/2011; 10(4):2664-70. DOI:10.4238/2011.October.31.17 · 0.78 Impact Factor
Show more